Trial intelligence / Profile preview

Plasmin for PVD creation

NCT00347646Phase 2Terminated

Sponsor
Bausch + Lomb
Start
Sep 2006
Primary completion
May 2007
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 2 trial of plasmin in Vitreomacular traction syndrome (VMT), sponsored by Bausch + Lomb. Started Sep 2006; status: terminated.

02

Drugs

plasmin
03

Conditions

Vitreomacular traction syndrome (VMT)

Beyond the preview

Go deeper on NCT00347646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00347646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call